Loscalzo J, Kohane I, Barabasi AL: Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol. 2007, 3: 124.
Article
PubMed
PubMed Central
Google Scholar
Butte AJ: Medicine. The ultimate model organism. Science. 2008, 320: 325-327.
Article
CAS
PubMed
PubMed Central
Google Scholar
Itadani H, Mizuarai S, Kotani H: Can systems biology understand pathway activation? Gene expression signatures as surrogate markers for understanding the complexity of pathway activation. Curr Genomics. 2008, 9: 349-360.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu JG, Campen A, Huang SG, Peng SB, Ye X, Palakal M, Dunker AK, Xia YN, Li SY: Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data. BMC Med Genet. 2008, 1: 39.
Google Scholar
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752.
Article
CAS
PubMed
Google Scholar
Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001, 98: 10869-10874.
Article
CAS
PubMed
PubMed Central
Google Scholar
van de Vijver MJ, He YD, van ’t Veer LJ, Dai H, Hart AAM, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002, 347: 1999-2009.
Article
CAS
PubMed
Google Scholar
Bandres E, Malumbres R, Cubedo E, Honorato B, Zarate R, Labarga A, Gabisu U, Sola JJ, Garcia-Foncillas J: A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes’ B colon cancer patients. Oncol Rep. 2007, 17: 1089-1094.
CAS
PubMed
Google Scholar
Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC: A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med. 2007, 356: 11-20.
Article
CAS
PubMed
Google Scholar
Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, Layden TJ, Wright TL, White T, Cheung RC: A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007, 46: 297-306.
Article
CAS
PubMed
Google Scholar
Okahara S, Arimura Y, Yabana T, Kobayashi K, Gotoh A, Motoya S, Imamura A, Endo T, Imai K: Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis. Aliment Pharmacol Ther. 2005, 21: 1091-1097.
Article
CAS
PubMed
Google Scholar
Koscielny S: Why most gene expression signatures of tumors have not been useful in the clinic. Sci Transl Med. 2010, 2: 14ps12.
Article
Google Scholar
Dowsett M, Sestak I, Lopez-Knowles E, Sidhu K, Dunbier AK, Cowens JW, Ferree S, Storhoff J, Schaper C, Cuzick J: Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. J Clin Oncol. 2013, 31: 2783-2790.
Article
PubMed
Google Scholar
Ein-Dor L, Kela I, Getz G, Givol D, Domany E: Outcome signature genes in breast cancer: is there a unique set?. Bioinformatics. 2005, 21: 171-178.
Article
CAS
PubMed
Google Scholar
Ein-Dor L, Zuk O, Domany E: Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci U S A. 2006, 103: 5923-5928.
Article
CAS
PubMed
PubMed Central
Google Scholar
Draghici S, Khatri P, Eklund AC, Szallasi Z: Reliability and reproducibility issues in DNA microarray measurements. Trends Genet. 2006, 22: 101-109.
Article
CAS
PubMed
Google Scholar
Barabasi AL, Oltvai ZN: Network biology: understanding the cell’s functional organization. Nat Rev Genet. 2004, 5: 101-113.
Article
CAS
PubMed
Google Scholar
van’t Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002, 415: 530-536.
Article
Google Scholar
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, Atkins D, Foekens JA: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005, 365: 671-679.
Article
CAS
PubMed
Google Scholar
Drier Y, Domany E: Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes?. Plos One. 2011, 6 (3): e17795.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oti M, Brunner HG: The modular nature of genetic diseases. Clin Genet. 2007, 71: 1-11.
Article
CAS
PubMed
Google Scholar
Gonen M: Statistical aspects of gene signatures and molecular targets. Gastrointest Cancer Res. 2009, 3: S19-S21.
PubMed
PubMed Central
Google Scholar
Thomas DC, Baurley JW, Brown EE, Figueiredo JC, Goldstein A, Hazra A, Wilson RT, Rothman N: Approaches to complex pathways in molecular epidemiology: summary of a Special Conference of the American Association for Cancer Research. Cancer Res. 2008, 68: 10028-10030.
Article
CAS
PubMed
Google Scholar
Chin L, Hahn WC, Getz G, Meyerson M: Making sense of cancer genomic data. Genes Dev. 2011, 25: 534-555.
Article
CAS
PubMed
PubMed Central
Google Scholar
Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR: MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 2003, 4: R7.
Article
PubMed
PubMed Central
Google Scholar
Segal E, Friedman N, Koller D, Regev A: A module map showing conditional activity of expression modules in cancer. Nat Genet. 2004, 36: 1090-1098.
Article
CAS
PubMed
Google Scholar
Bild AH, Yao G, Chang JT, Wang QL, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA, Marks JR, Dressman HK, West M, Nevins JR: Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006, 439: 353-357.
Article
CAS
PubMed
Google Scholar
Emmert-Streib F, Glazko GV: Pathway Analysis of expression data: deciphering functional building blocks of complex diseases. Plos Comput Biol. 2011, 7: e1002053.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cary MP, Bader GD, Sander C: Pathway information for systems biology. FEBS Letters. 2005, 579: 1815-1820.
Article
CAS
PubMed
Google Scholar
Kim S, Kon M, DeLisi C: Pathway-based classification of cancer subtypes. Biol Direct. 2012, 7: 21.
Article
PubMed
PubMed Central
Google Scholar
Hung JH, Whitfield TW, Yang TH, Hu Z, Weng Z, DeLisi C: Identification of functional modules that correlate with phenotypic difference: the influence of network topology. Genome Biol. 2010, 11: R23.
Article
PubMed
PubMed Central
Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005, 102: 15545-15550.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vaske CJ, Benz SC, Sanborn JZ, Earl D, Szeto C, Zhu JC, Haussler D, Stuart JM: Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics. 2010, 26: i237-i245.
Article
CAS
PubMed
PubMed Central
Google Scholar
Drier Y, Sheffer M, Domany E: Pathway-based personalized analysis of cancer. Proc Natl Acad Sci U S A. 2013, 110: 6388-6393.
Article
CAS
PubMed
PubMed Central
Google Scholar
Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, Fulton LL, Dooling DJ, Ding L, Mardis ER, Wilson RK, Ally A, Balasundaram M, Butterfield YSN, Carlsen R, Carter C, Chu A, Chuah E, Chun HJE, Coope RJN, Dhalla N, Guin R, Hirst C, Hirst M, Holt RA, Lee D, Li HYI, Mayo M, Moore RA, Mungall AJ, et al: Comprehensive molecular portraits of human breast tumours. Nature. 2012, 490: 61-70.
Article
CAS
Google Scholar
Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Langerod A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Borresen-Dale AL, Brenton JD, Tavare S, Caldas C, et al: The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012, 486: 346-352.
CAS
PubMed
PubMed Central
Google Scholar
Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F, Dhir R, DiSaia P, Gabra H, Glenn P, Godwin AK, Gross J, Hartmann L, Huang M, Huntsman DG, Iacocca M, Imielinski M, Kalloger S, Karlan BY, Levine DA, Mills GB, Morrison C, Mutch D, Olvera N, Orsulic S, Park K, Petrelli N, Rabeno B, Rader JS, Sikic BI, et al: Integrated genomic analyses of ovarian carcinoma. Nature. 2011, 474: 609-615.
Article
CAS
Google Scholar
Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28: 27-30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cline MS, Craft B, Swatloski T, Goldman M, Ma S, Haussler D, Zhu J: Exploring TCGA Pan-Cancer data at the UCSC Cancer Genomics Browser. Sci Rep. 2013, 3: 2652.
Article
PubMed
PubMed Central
Google Scholar
Hung JH, Yang TH, Hu ZJ, Weng ZP, DeLisi C: Gene set enrichment analysis: performance evaluation and usage guidelines. Brief Bioinform. 2012, 13: 281-291.
Article
PubMed
Google Scholar
Alexe G, Dalgin GS, Scanfeld D, Tamayo P, Mesirov JP, DeLisi C, Harris L, Barnard N, Martel M, Levine AJ, Ganesan S, Bhanot G: High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. Cancer Res. 2007, 67: 10669-10676.
Article
CAS
PubMed
Google Scholar
Eroles P, Bosch A, Perez-Fidalgo JA, Lluch A: Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev. 2012, 38: 698-707.
Article
CAS
PubMed
Google Scholar
Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DSA, Nobel AB, van’t Veer LJ, Perou CM: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006, 355: 560-569.
Article
CAS
PubMed
Google Scholar
Benjamini Y, Hochberg Y: Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Methodological. 1995, 57: 289-300.
Google Scholar
Li ZG, Su ZQ, Wen ZN, Shi LM, Chen T: Microarray platform consistency is revealed by biologically functional analysis of gene expression profiles. BMC Bioinformatics. 2009, 10 (Suppl 11): S12.
Article
PubMed
PubMed Central
Google Scholar
Chuang HY, Lee E, Liu YT, Lee D, Ideker T: Network-based classification of breast cancer metastasis. Mol Syst Biol. 2007, 3: 140.
Article
PubMed
PubMed Central
Google Scholar
Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y: RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 2008, 18: 1509-1517.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Z, Gerstein M, Snyder M: RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009, 10: 57-63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Khatri P, Sirota M, Butte AJ: Ten Years of pathway analysis: current approaches and outstanding challenges. Plos Comput Biol. 2012, 8: e1002375.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dang CV: Links between metabolism and cancer. Genes Dev. 2012, 26: 877-890.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernadez V, Hartmann E, Ott G, Campo E, Rosenwald A: Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol. 2005, 23: 6364-6369.
Article
Google Scholar
Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, et al: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008, 321: 1801-1806.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pham L, Christadore L, Schaus S, Kolaczyk ED: Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis. Proc Natl Acad Sci U S A. 2011, 108: 13347-13352.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cully M, You H, Levine AJ, Mak TW: Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer. 2006, 6: 184-192.
Article
CAS
PubMed
Google Scholar
Al-Hussaini H, Subramanyam D, Reedijk M, Sridhar SS: Notch signaling pathway as a therapeutic target in breast cancer. Mol Cancer Ther. 2011, 10: 9-15.
Article
CAS
PubMed
Google Scholar
Osborne CK, Shou J, Massarweh S, Schiff R: Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Clin Cancer Res. 2005, 11: 865s-870s.
CAS
PubMed
Google Scholar
Yu ZR, Wang LP, Wang CG, Ju XM, Wang M, Chen K, Loro E, Li ZP, Zhang YZ, Wu KM, Casimiro MC, Gormley M, Ertel A, Fortina P, Chen YH, Tozeren A, Liu ZM, Pestell RG: Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer. Nat Commun. 2013, 4: 2812.
PubMed
PubMed Central
Google Scholar
Pontano LL, Aggarwal P, Barbash O, Brown EJ, Bassing CH, Diehl JA: Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability. Mol Cell Biol. 2008, 28: 7245-7258.
Article
CAS
PubMed
PubMed Central
Google Scholar
Graeser M, McCarthy A, Lord CJ, Savage K, Hills M, Salter J, Orr N, Parton M, Smith IE, Reis JS, Dowsett M, Ashworth A, Turner NC: A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res. 2010, 16: 6159-6168.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stefansson OA, Jonasson JG, Olafsdottir K, Bjarnason H, Th Johannsson O, Bodvarsdottir SK, Valgeirsdottir S, Eyfjord JE: Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression. Breast Cancer Res. 2011, 13: R95.
Article
CAS
PubMed
PubMed Central
Google Scholar
Banda M, Speyer C, Gorski D: Metabotropic glutamate receptor-1 is oncogenic in triple-negative breast cancer. Ann Surg Oncol. 2012, 19: 23-23.
Google Scholar
Budczies J, Denkert C, Muller BM, Brockmoller SF, Klauschen F, Gyorffy B, Dietel M, Richter-Ehrenstein C, Marten U, Salek RM, Griffin JL, Hilvo M, Oresic M, Wohlgemuth G, Fiehn O: Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study. BMC Genomics. 2012, 13: 334.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hynes NE, MacDonald G: ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol. 2009, 21: 177-184.
Article
CAS
PubMed
Google Scholar
Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG: Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005, 26: 1241-1246.
Article
CAS
PubMed
Google Scholar
Wu J, Hu Z, DeLisi C: Gene annotation and network inference by phylogenetic profiling. BMC Bioinformatics. 2006, 7: 80.
Article
PubMed
PubMed Central
Google Scholar
Perez-Llamas C, Lopez-Bigas N: Gitools: analysis and visualisation of genomic data using interactive heat-maps. Plos One. 2011, 6: e19541.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu Z, Mellor J, DeLisi C: Analyzing networks with VisANT. Curr Protoc Bioinformatics. 2004, 8: Chapter 8:Unit 8.8.1-24
Google Scholar
Hu Z, Mellor J, Wu J, DeLisi C: VisANT: an online visualization and analysis tool for biological interaction data. BMC Bioinformatics. 2004, 5: 17.
Article
PubMed
PubMed Central
Google Scholar
Hu Z, Ng DM, Yamada T, Chen C, Kawashima S, Mellor J, Linghu B, Kanehisa M, Stuart JM, DeLisi C: VisANT 3.0: new modules for pathway visualization, editing, prediction and construction. Nucleic Acids Res. 2007, 35: W625-W632.
Article
PubMed
PubMed Central
Google Scholar
Hu Z, Snitkin ES, DeLisi C: VisANT: an integrative framework for networks in systems biology. Brief Bioinform. 2008, 9: 317-325.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu Z, Chang YC, Wang Y, Huang CL, Liu Y, Tian F, Granger B, Delisi C: VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies. Nucleic Acids Res. 2013, 41: W225-W231.
Article
PubMed
PubMed Central
Google Scholar
Hu Z, Mellor J, Wu J, Yamada T, Holloway D, Delisi C: VisANT: data-integrating visual framework for biological networks and modules. Nucleic Acids Res. 2005, 33: W352-W357.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hu Z, Mellor J, Wu J, Kanehisa M, Stuart JM, DeLisi C: Towards zoomable multidimensional maps of the cell. Nat Biotechnol. 2007, 25: 547-554.
Article
CAS
PubMed
Google Scholar
Hu Z, Hung JH, Wang Y, Chang YC, Huang CL, Huyck M, DeLisi C: VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology. Nucleic Acids Res. 2009, 37: W115-W121.
Article
CAS
PubMed
PubMed Central
Google Scholar
Polyak K: Breast cancer: origins and evolution. J Clin Invest. 2007, 117: 3155-3163.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cleary MP, Grossmann ME: Minireview: obesity and breast cancer: the estrogen connection. Endocrinology. 2009, 150: 2537-2542.
Article
CAS
PubMed
PubMed Central
Google Scholar
Piccirilli M, Salvati M, Bistazzoni S, Frati A, Brogna C, Giangaspero F, Frati R, Santoro A: Glioblastoma multiforme and breast cancer: report on 11 cases and clinico-pathological remarks. Tumori. 2005, 91: 256-260.
PubMed
Google Scholar
Leslie KK, Keefe D, Powell S, Naftolin F: Estrogen receptors are identified in the glioblastoma cell line U138MG. J Soc Gynecol Investig. 1994, 1: 238-244.
CAS
PubMed
Google Scholar
Mineo JF, Bordron A, Baroncini M, Maurage CA, Ramirez C, Siminski RM, Berthou C, Dam Hieu P: Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma. J Neurooncol. 2007, 85: 281-287.
Article
PubMed
Google Scholar
Lawrence JE, Cook NJ, Rovin RA, Winn RJ: Leptin promotes glioblastoma. Neurol Res Int. 2012, 2012: 870807.
Article
PubMed
PubMed Central
Google Scholar
Ulitsky I, Shamir R: Identification of functional modules using network topology and high-throughput data. BMC Syst Biol. 2007, 1: 8.
Article
PubMed
PubMed Central
Google Scholar
Gatenby RA, Gillies RJ: Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004, 4: 891-899.
Article
CAS
PubMed
Google Scholar
Ruckhaberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, Grosch S, Geisslinger G, Holtrich U, Karn T, Kaufmann M: Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat. 2008, 112: 41-52.
Article
PubMed
Google Scholar
Schramm G, Surmann EM, Wiesberg S, Oswald M, Reinelt G, Eils R, Konig R: Analyzing the regulation of metabolic pathways in human breast cancer. BMC Med Genomics. 2010, 3: 39.
Article
PubMed
PubMed Central
Google Scholar
Miecznikowski JC, Wang D, Liu S, Sucheston L, Gold D: Comparative survival analysis of breast cancer microarray studies identifies important prognostic genetic pathways. BMC Cancer. 2010, 10: 573.
Article
PubMed
PubMed Central
Google Scholar
Singh R, Pervin S, Karimi A, Cederbaum S, Chaudhuri G: Arginase activity in human breast cancer cell lines: N (omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res. 2000, 60: 3305-3312.
CAS
PubMed
Google Scholar
Hitosugi T, Fan J, Chung TW, Lythgoe K, Wang X, Xie JX, Ge QY, Gu TL, Polakiewicz RD, Roesel JL, Chen GZ, Boggon TJ, Lonial S, Fu HA, Khuri FR, Kang SM, Chen J: Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell. 2011, 44: 864-877.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fong MY, McDunn J, Kakar SS: Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer. PLoS One. 2011, 6: e19963.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Santella RM: One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 2005, 65: 1606-1614.
Article
CAS
PubMed
Google Scholar
Jacquemont C, Taniguchi T: The Fanconi anemia pathway and ubiquitin. BMC Biochem. 2007, 8 (Suppl 1): S10.
Article
PubMed
PubMed Central
Google Scholar
Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB: Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005, 4: 988-1004.
Article
CAS
PubMed
Google Scholar
Yamaguchi H, Condeelis J: Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim BiophysActa. 2007, 1773: 642-652.
CAS
Google Scholar
Golubovskaya V, Beviglia L, Xu LH, Earp HS, Craven R, Cance W: Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. J Biol Chem. 2002, 277: 38978-38987.
Article
CAS
PubMed
Google Scholar
Housa D, Housova J, Vernerova Z, Haluzik M: Adipocytokines and cancer. Physiol Res. 2006, 55: 233-244.
CAS
PubMed
Google Scholar
Chedotal A, Kerjan G, Moreau-Fauvarque C: The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ. 2005, 12: 1044-1056.
Article
CAS
PubMed
Google Scholar